[Update of Chlamydia trachomatis infection]

Area of Science:

• Reproductive Health
• Infectious Diseases
• Genetics

Background:

• Chlamydia trachomatis (CT) is the leading global bacterial STI, frequently asymptomatic and impacting young women.
• CT sequelae include pelvic inflammatory disease, tubal infertility, and obstetric complications; male fertility impact is debated.
• Concerns regarding antibiotic resistance and urogenital microbiota disruption necessitate reassessment of CT screening and treatment.

Purpose of the Study:

• To investigate the association between CT seropositivity and tuboperitoneal pathology.
• To explore the role of single-nucleotide polymorphisms (SNPs) in identifying individuals at higher risk for CT-induced tubal damage.
• To evaluate CT seropositivity as a predictor of spontaneous pregnancy rates and obstetric complications.

Main Methods:

• Analysis of CT serology in relation to tuboperitoneal pathology.
• Investigation of single-nucleotide polymorphisms (SNPs) for risk profiling of infectious tubal damage.
• Statistical evaluation of CT seropositivity and its correlation with fertility and pregnancy outcomes.

Main Results:

• Positive CT serology may indicate tuboperitoneal pathology not always detected by hysterosalpingography.
• CT seropositivity is linked to reduced spontaneous pregnancy rates.
• CT seropositivity serves as a predictive factor for obstetric complications.

Conclusions:

• CT screening and management require updated approaches considering resistance and microbiota effects.
• Identifying genetic predispositions through SNPs could refine risk assessment for CT-related tubal damage.
• CT serology is a valuable indicator for reproductive and obstetric risk assessment in women.